The Norris Cotton Cancer Center (NCCC) is a Comprehensive Cancer Center which has had support from the National Cancer Institute for the past 18 years. The NCCC is a component of the Dartmouth-Hitchcock Medical Center (DHMC) that has the overall responsibility for cancer research on this campus. The cancer research programs in the NCCC are facilitated by an administrative structure in which the Director, who is appointed as an Assoc. Vice President reports to the board of Trustees of the DHMC through the Senior Operations committee. Program development and planning in the NCCC are facilitated by: the Senior Leadership Group, which consists of a Deputy Director, Associate Director for Cancer Control, and the NCCC administrator; and an Executive Committee comprised of the Senior Leadership Group, the leaders of all the Research Programs, the chair of the Cancer Committee of the Mary Hitchcock Memorial Hospital, and the Directors of the Shared Resources. The NCCC supports Research Programs in Cancer Etiology, Cancer Prevention, Cell/Molecular Biology, Clinical Therapeutics, Developmental Therapeutics, Endocrinology, Immunology, and Radiation/Bioengineering. The goal of these programs is interactive, multi-disciplinary research which might have translational value. The NCCC provides shared resources for its investigators in biostatistics, clinical pharmacology, clinical research , editorial services, flow cytometry and fluorescence imaging, glassware washing,hybridoma library and monoclonal antibody production, irradiation, macromolecular core laboratory services, and tissue/sera procurement and histology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-20
Application #
2442932
Study Section
Cancer Center Support Review Committee (CCS)
Program Officer
Mccormick, Patricia
Project Start
1978-09-01
Project End
1998-11-30
Budget Start
1997-08-04
Budget End
1998-11-30
Support Year
20
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Bronson, Mackenzie R; Kapadia, Nirav S; Austin, Andrea M et al. (2018) Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer. Med Care 56:e83-e89
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Hancock, D B; Guo, Y; Reginsson, G W et al. (2018) Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence. Mol Psychiatry 23:1-9
Li, Yafang; Xiao, Xiangjun; Han, Younghun et al. (2018) Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis 39:336-346
Gorlov, Ivan; Orlow, Irene; Ringelberg, Carol et al. (2018) Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res 28:380-389
Shiner, Brian; Westgate, Christine Leonard; Gui, Jiang et al. (2018) A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice. J Clin Psychiatry 79:
Wu, Wenting; 23andMe Research Team; Amos, Christopher I et al. (2018) Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. J Invest Dermatol 138:2072-2075
Downey-Kopyscinski, Sondra; Daily, Ellen W; Gautier, Marc et al. (2018) An inhibitor of proteasome ?2 sites sensitizes myeloma cells to immunoproteasome inhibitors. Blood Adv 2:2443-2451
Varn, Frederick S; Tafe, Laura J; Amos, Christopher I et al. (2018) Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy. Oncoimmunology 7:e1431084

Showing the most recent 10 out of 1911 publications